Sort
130,381 grants matching “hiv”
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,261,890University Of Alabama At Birmingham · U01 · FY2003 · AI
CENTER FOR AIDS INTERVENTION RESEARCH--CORE SUPPORT
$1,261,834Medical College Of Wisconsin · P30 · FY2003 · MH
Optimizing HIV Care in Less Developed Countries
$1,261,747Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2009 · AI
INCREASING ACCESS TO AND UPTAKE OF HIV PREVENTION, CONFIDENTIAL VOLUNTARY COUNSEL
$1,261,461Harintsoa Lalah Rambeloson · Population Services International · U2G · FY2013 · PS
NHGRI/DIR Technology Transfer Program
$1,261,312Eric Green · National Human Genome Research Institute · ZIK · FY2010 · HG
Computational biology scientific research support component
$1,261,104Thomas B Kepler · Duke University · UM1 · FY2013 · AI
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$1,260,778Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2022 · AI
Molecular Mechanisms of HIV Latency
$1,260,763Eric M Verdin · Buck Institute For Research On Aging · R01 · FY2021 · DA
Molecular Mechanisms of HIV Latency
$1,260,763Eric M Verdin · Buck Institute For Research On Aging · R01 · FY2020 · DA
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism
$1,260,610Steffanie A Strathdee · University Of California, San Diego · R01 · FY2022 · DA
GH15-1508 - Expand Coverage and Improve the Quality of Facility and Community Based Prevention of Mother to Child Transmission of HIV (PMTCT) Support for Rollout of Option B+ Services ... (Cameroon)
$1,260,346Elaine Janine Abrams · Columbia University Health Sciences · U2G · FY2016 · GH
Contributions of durable, high-avidity T-cell responses to protection achieved using the Opti-FliP vaccine regimen
$1,260,330Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2025 · AI
Non-Human Primate Core (NHP Core)
$1,260,301Koen K Van Rompay · Duke University · P01 · FY2016 · AI
NextGen Long-acting and targeted combination ART for Children with HIV
$1,260,148Rodney J.y. Ho · University Of Washington · R33 · FY2022 · AI
Multicenter AIDS Cohort Study
$1,260,025Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
University of California, Berkeley (UCB)/University of *
$1,260,000Arthur L. Reingold · University Of California Berkeley · D43 · FY2006 · TW
Evaluation of anal self-sampling in HIV populations
$1,259,901Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
STRUCTURAL BIOLOGY AND TARGETED DRUG DESIGN FOR AIDS
$1,259,788University Of California San Francisco · P01 · FY2000 · GM
Seek, Test, Treat: An Integrated Jail-Prison-Community Model for Illinois
$1,259,429Lawrence J Ouellet · University Of Illinois At Chicago · R01 · FY2010 · DA
1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial
$1,259,310Robert J Kaner · Weill Medical Coll Of Cornell Univ · UH3 · FY2024 · HL
Aurum Clinical Trials Unit
$1,258,716Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2022 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,258,577Eric Hunter · Emory University · R01 · FY2006 · AI
Sputum Transcriptomic Expression Profiling in Study 31: Express 31
$1,258,441Payam Nahid · University Of California, San Francisco · R01 · FY2018 · AI
Human Tissue and Organ Resource for Research
$1,258,033John T Lonsdale · National Disease Research Interchange · U42 · FY2006 · RR
Computational biology scientific research support component
$1,257,775Thomas B Kepler · Duke University · UM1 · FY2018 · AI